Mercy Medical Center Completes Beta Studies for Integrated Hematology and Automated Diabetes Testin...( MUNDELEIN Ill. April 22 /- Sysmex...)

MUNDELEIN, Ill., April 22 /PRNewswire/ -- Sysmex America, Inc. today announced the successful completion of Mercy Medical Center's (Canton, OH) beta studies for its integrated hematology and A1C automation solution. This first-of-kind solution, which combines the Sysmex HST-N hematology automation platform and the Bio-Rad Laboratories, Inc. VARIANT(TM) II TURBO Link, enables on-demand, automated diabetes testing in a random access setting. "This integrated testing solution, now fully on-line at Mercy, also utilizes automated decision logic rules software, Sysmex MOLIS WAM(TM), to maximize efficiencies in the area of data and sample management and labor utilization," said Barbara Carter, Coordinator Automated/Core Laboratory, Mercy Medical Center. Mercy Medical Center's early adoption of the integrated hematology and A1C Testing Solution aligns with the hospital's impressive list of world, national, state and Stark county's "firsts." The hospital is jointly owned and operated by the Sisters of Charity Health System and University Hospitals Health System. This integrated testing Solution will be available to hospitals across the nation beginning the end of April 2008.

"As an early adopter of the automated A1C Testing Solution, we are providing superior diabetes testing services that positively impact the quality and timeliness of the acute care and management of diabetic patients. With diabetes affecting over 20 million children and adults in the United States, coupled with the nation's obesity epidemic, we saw the need to create a laboratory infrastructure for the future," said Mary Ann Burich-Boccia, Administrative Director, Laboratory, Mercy Medical Center. "By automating and consolidating our high volume hematology and diabetes testing, we have dramatically improved our operational efficiency while reducing costs and errors. And, with seventy-five percent of our samples no longer needing technologist-touch, we are freeing our technologists for more c
'/>"/>